Cytek Biosciences, Inc. financial data

Symbol
CTKB on Nasdaq
Industry
Laboratory Analytical Instruments
Location
47215 Lakeview Boulevard, Fremont, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 726 % -22.1%
Quick Ratio 111 % -1.2%
Debt-to-equity 25 % +16.4%
Return On Equity -2.93 % -590%
Return On Assets -2.35 % -573%
Operating Margin -13.2 % +94.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 131M shares -3.24%
Common Stock, Shares, Outstanding 131M shares -3.24%
Entity Public Float 1.03B USD
Common Stock, Value, Issued 131K USD -3.68%
Weighted Average Number of Shares Outstanding, Basic 131M shares -3.37%
Weighted Average Number of Shares Outstanding, Diluted 131M shares -3.37%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 201M USD +3926%
Revenue from Contract with Customer, Excluding Assessed Tax 201M USD +20.9%
Research and Development Expense 44M USD +19.5%
Selling and Marketing Expense 50.5M USD +35.1%
General and Administrative Expense 43.3M USD +10.4%
Operating Income (Loss) -26.4M USD -128%
Nonoperating Income (Expense) 10.8M USD +50.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.7M USD -250%
Income Tax Expense (Benefit) -4.15M USD -79.6%
Net Income (Loss) Attributable to Parent -12.1M USD -589%
Earnings Per Share, Basic -0.09 USD/shares -550%
Earnings Per Share, Diluted -0.09 USD/shares -550%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 169M USD +30.4%
Accounts Receivable, after Allowance for Credit Loss, Current 50.3M USD +16.7%
Inventory, Net 54.7M USD -21.2%
Other Assets, Current 2.49M USD +75%
Assets, Current 389M USD -8.69%
Property, Plant and Equipment, Net 18.2M USD +17.4%
Operating Lease, Right-of-Use Asset 9.95M USD -24.6%
Intangible Assets, Net (Excluding Goodwill) 22.3M USD -9.78%
Goodwill 16.2M USD -15.5%
Other Assets, Noncurrent 4.08M USD +35.8%
Assets 492M USD -6.2%
Accrued Liabilities, Current 18.1M USD -11.4%
Contract with Customer, Liability, Current 38.2M USD +22.7%
Liabilities, Current 55.6M USD -1.68%
Operating Lease, Liability, Noncurrent 8.7M USD -24.6%
Other Liabilities, Noncurrent 1.83M USD -2.14%
Liabilities 99.5M USD -1.64%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.55M USD -165%
Retained Earnings (Accumulated Deficit) -35.3M USD -48.3%
Stockholders' Equity Attributable to Parent 393M USD -7.28%
Liabilities and Equity 492M USD -6.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.96M USD +38.5%
Net Cash Provided by (Used in) Financing Activities 1.61M USD
Net Cash Provided by (Used in) Investing Activities -5.75M USD +96.6%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 131M shares -3.24%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.51M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 169M USD +27.8%
Deferred Tax Assets, Valuation Allowance 2.27M USD +81.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 36M USD +39.7%
Operating Lease, Liability 11M USD -24.5%
Depreciation 3.1M USD +63.2%
Payments to Acquire Property, Plant, and Equipment 567K USD +12.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.5M USD -241%
Lessee, Operating Lease, Liability, to be Paid 11.6M USD -25.4%
Property, Plant and Equipment, Gross 24.4M USD +26.9%
Operating Lease, Liability, Current 2.28M USD -24.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.5M USD -19.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.55M USD +2.37%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -10M USD +11.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 626K USD -38.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.32M USD -13.7%
Deferred Tax Assets, Operating Loss Carryforwards 1.41M USD +87.3%
Deferred Federal Income Tax Expense (Benefit) -8.78M USD +4.22%
Current Income Tax Expense (Benefit) 6.47M USD -35.7%
Unrecognized Tax Benefits 3.64M USD +62.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.05M USD -20.6%
Additional Paid in Capital 429M USD -4.1%
Current State and Local Tax Expense (Benefit) 798K USD -40.4%
Current Federal Tax Expense (Benefit) 4.14M USD -43.1%
Amortization of Intangible Assets 3.7M USD +337%
Depreciation, Depletion and Amortization 1.7M USD +69.7%
Deferred Tax Assets, Net of Valuation Allowance 33.7M USD +37.5%
Share-based Payment Arrangement, Expense 23M USD +31.7%
Deferred State and Local Income Tax Expense (Benefit) -1.17M USD +38.7%
Interest Expense 1.84M USD -30.8%